Cardiology Involvement and Mortality in Adult Patients with Advanced Solid Cancer Complicated by Atrial Fibrillation

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2025 Feb 25

PMID 39999078

Authors

Takeshi Sato

Zhehao Dai

Jun Hashimoto

Sachiko Ohde

Nobuyuki Komiyama

Takayuki Inomata

Teruo Yamauchi

Affiliations

Soon will be listed here.

Abstract

Background: The association between comorbid atrial fibrillation (AF) and survival in adult patients with advanced solid cancer, as well as the impact of cardiology involvement in such patients, remains unclear.

Methods: This retrospective cohort study included adult patients diagnosed with advanced solid cancers. We calculated prevalence of AF in different cancer types and compared all-cause mortality between patients with and without AF. We further examined the association between cardiology involvement and mortality in the subset of participants with AF.

Results: Among the 1,349 adult patients with advanced solid cancer, 122 (9.0%) had AF. The risk of AF was the highest in lung and mediastinal cancer (15.6%). AF was associated with higher all-cause mortality, which became neutral after adjustment for age, sex, comorbidities, cancer types and cancer treatments (crude hazard ratio [HR] 1.39, 95% confidence interval [CI] 1.11-1.75, p = 0.004; adjusted HR 1.08, 95%CI 0.84-1.39, p = 0.552). In those with AF, cardiology involvement was independently associated with lower all-cause mortality (age, sex, comorbidities, cancer types and cancer treatments-adjusted HR 0.50 [95%CI 0.28-0.88], p = 0.017), though the cumulative incidence of neither cardiovascular nor non-cardiovascular death differed significantly between patients who received cardiology care and those who did not.

Conclusions: In adult patients with advanced solid cancer, AF per se was not independently associated with increased mortality. Cardiology involvement in patients with advanced solid cancer and AF was linked to a better overall survival, but with low certainty that this finding is not attributable to unmeasured confounding.

References

Chin J, Moon Y, Jo J, Han Y, Kim H, Lee E . Association between Postoperatively Developed Atrial Fibrillation and Long-Term Mortality after Esophagectomy in Esophageal Cancer Patients: An Observational Study. PLoS One. 2016; 11(5):e0154931. PMC: 4858232. DOI: 10.1371/journal.pone.0154931. View

ONeal W, Claxton J, Sandesara P, MacLehose R, Chen L, Bengtson L . Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer. J Am Coll Cardiol. 2018; 72(16):1913-1922. PMC: 6512871. DOI: 10.1016/j.jacc.2018.07.077. View

Hu Y, Liu C, Chang P, Tsao H, Lin Y, Chang S . Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients. Int J Cardiol. 2012; 165(2):355-7. DOI: 10.1016/j.ijcard.2012.08.036. View

Curigliano G, Lenihan D, Fradley M, Ganatra S, Barac A, Blaes A . Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol. 2020; 31(2):171-190. PMC: 8019325. DOI: 10.1016/j.annonc.2019.10.023. View

Hajjar L, Fonseca S, Machado T . Atrial Fibrillation and Cancer. Front Cardiovasc Med. 2021; 8:590768. PMC: 8319502. DOI: 10.3389/fcvm.2021.590768. View

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax J, Blomstrom-Lundqvist C . 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the.... Eur Heart J. 2020; 42(5):373-498. DOI: 10.1093/eurheartj/ehaa612. View

Hussain M, Misbah R, Donnellan E, Alkharabsheh S, Hou Y, Cheng F . Impact of timing of atrial fibrillation, CHADS-VASc score and cancer therapeutics on mortality in oncology patients. Open Heart. 2020; 7(2). PMC: 7692982. DOI: 10.1136/openhrt-2020-001412. View

Guha A, Fradley M, Dent S, Weintraub N, Lustberg M, Alonso A . Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis. Eur Heart J. 2021; 43(4):300-312. PMC: 8914878. DOI: 10.1093/eurheartj/ehab745. View

Yun J, Choi E, Han K, Park S, Jung J, Park S . Risk of Atrial Fibrillation According to Cancer Type: A Nationwide Population-Based Study. JACC CardioOncol. 2021; 3(2):221-232. PMC: 8352078. DOI: 10.1016/j.jaccao.2021.03.006. View

10.

Lyon A, Lopez-Fernandez T, Couch L, Asteggiano R, Aznar M, Bergler-Klein J . 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022; 43(41):4229-4361. DOI: 10.1093/eurheartj/ehac244. View

11.

Patell R, Gutierrez A, Rybicki L, Khorana A . Usefulness of CHADS2 and CHA2DS2-VASc Scores for Stroke Prediction in Patients With Cancer and Atrial Fibrillation. Am J Cardiol. 2017; 120(12):2182-2186. DOI: 10.1016/j.amjcard.2017.08.038. View

12.

Dsouza M, Carlson N, Fosbol E, Lamberts M, Smedegaard L, Nielsen D . CHADS-VASc score and risk of thromboembolism and bleeding in patients with atrial fibrillation and recent cancer. Eur J Prev Cardiol. 2018; 25(6):651-658. DOI: 10.1177/2047487318759858. View

13.

Han H, Chen L, Lin Z, Wei X, Guo W, Yu Y . Prevalence, trends, and outcomes of atrial fibrillation in hospitalized patients with metastatic cancer: findings from a national sample. Cancer Med. 2021; 10(16):5661-5670. PMC: 8366074. DOI: 10.1002/cam4.4105. View

14.

Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler K . 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. Europace. 2021; 23(10):1612-1676. PMC: 11636576. DOI: 10.1093/europace/euab065. View

15.

Mertens A, Liu Q, Neglia J, Wasilewski K, Leisenring W, Armstrong G . Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2008; 100(19):1368-79. PMC: 2556702. DOI: 10.1093/jnci/djn310. View

16.

Guzzetti S, Costantino G, Sada S, Fundaro C . Colorectal cancer and atrial fibrillation: a case-control study. Am J Med. 2002; 112(7):587-8. DOI: 10.1016/s0002-9343(02)01029-x. View

17.

Jakobsen C, Lamberts M, Carlson N, Lock-Hansen M, Torp-Pedersen C, Gislason G . Incidence of atrial fibrillation in different major cancer subtypes: a Nationwide population-based 12 year follow up study. BMC Cancer. 2019; 19(1):1105. PMC: 6854796. DOI: 10.1186/s12885-019-6314-9. View

18.

Jemal A, Ward E, Johnson C, Cronin K, Ma J, Ryerson B . Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival. J Natl Cancer Inst. 2017; 109(9). PMC: 5409140. DOI: 10.1093/jnci/djx030. View